Maternal-fetal Outcomes of Genital Blood Loss Beyond 18 Weeks of Pregnancy

Launched by IRCCS AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA · Jan 26, 2025

Keywords

ClinConnect Summary

This clinical trial is studying the effects of genital bleeding that occurs after 18 weeks of pregnancy. The main goal is to find out how often serious problems happen in these pregnancies, such as premature births, bleeding that affects both the mother and baby, or even deaths of the mother or baby. This research is important because it aims to better understand the risks associated with bleeding during this later stage of pregnancy.

To be eligible for this trial, women must be at least 18 years old and currently pregnant for more than 18 weeks with genital bleeding. There are no specific health issues that would exclude someone from joining the study. Participants will be monitored closely to track any complications that arise from their condition. The information gathered will help improve care for women experiencing similar issues in the future.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Pregnancy beyond 18 weeks gestational age complicated by genital bleeding;
• • Age of the patient ≥18 years;
• • Delivery at the O.U. of Obstetrics and Prenatal Age Medicine
• Exclusion Criteria:
• • None